The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2022

Filed:

Feb. 27, 2017
Applicant:

Japanese Foundation for Cancer Research, Tokyo, JP;

Inventors:

Toru Hirota, Tokyo, JP;

Yusuke Abe, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C07K 16/18 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
G01N 33/5011 (2013.01); C07K 16/18 (2013.01); G01N 33/574 (2013.01); G01N 33/6845 (2013.01); C07K 2317/30 (2013.01); C07K 2317/32 (2013.01); C07K 2317/70 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); G01N 2440/14 (2013.01); G01N 2500/02 (2013.01);
Abstract

The inventors have found that the interaction between HP1 and INCENP can serve as an indicator for chromosome instability and established a method for evaluating chromosome instability of cancer cells. The evaluation system can be used for screening of anticancer agent with a new-concept of targeting chromosome instability of cancer cells. The inventors further prepared an antibody for specifically recognizing phosphorylation of serine at position 92 of HP1α, by which the action of Aurora B can be evaluated. The interaction between HP1 and INCENP can be readily evaluated by the antibody.


Find Patent Forward Citations

Loading…